36 results
6-K
EX-99.2
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
the degree of market acceptance by physicians, healthcare payers, patients, and the medical community. Market acceptance will depend on a number … patient quality of life for patients with patients and the access globally healthcare community Be a diverse, equitable and inclusive, Be climate
6-K
EX-99.1
GLPG
Galapagos NV
3 Nov 23
Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023
8:26am
negatively impact acceptance of filgotinib by patients, the medical community, and healthcare payors, the risk that regulatory authorities may require
6-K
EX-99.1
GLPG
Galapagos NV
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
, and the risk that the EMA’s safety review may negatively impact acceptance of filgotinib by patients, the medical community, and healthcare payors
6-K
EX-99.2
GLPG
Galapagos NV
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
tenure at Janssen Pharmaceutica (a J&J Company), and I am thrilled to have the opportunity to be a part of the Galapagos community and work alongside … authorities’ safety review may negatively impact acceptance of filgotinib by patients, the medical community and healthcare payors, and the risks
6-K
EX-99.1
9xg9jqqfqtbplvdz
23 May 23
Galapagos demonstrates commitment to immunology with new data in rheumatoid arthritis at EULAR 2023
7:30am
6-K
EX-99.1
qqk5 3b9ye7
5 May 23
Galapagos announces first quarter 2023 financial results
4:05pm
6-K
EX-99.1
rvt6 yhp66u
9 Nov 22
Current report (foreign)
4:05pm
6-K
EX-99.1
dszr2sryc7254rflh29
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.2
miv s2ril9lcoqf
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.1
6r1 ovxmz6liu
4 Nov 22
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
4:57pm
6-K
EX-99.1
60m6alhgah5k lgu5eoa
6 Oct 22
Current report (foreign)
5:11pm
6-K
EX-99.1
lcblr6
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.2
rvdq hc8whx5fsps320
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.1
epgem f71
31 May 22
Current report (foreign)
1:39pm
6-K
EX-99.1
6rcy jtugk2q
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.2
0qfofoz1ji93g 1k8jcr
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.3
tgwhqwxs e9s0
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.1
lka0m
28 Mar 22
Jyseleca® approved in Japan for ulcerative colitis
1:50pm